Pakistan records largest single day rise in new infections; global deaths pass 380,000; Yemen aid funding falls short by US$1bn
- Exclusive: governments and WHO changed Covid policy bases on suspect data from tiny US company
- Architect of Sweden’s coronavirus strategy admits too many died
- Air pollution in China back to pre-Covid levels and Europe may follow
- UK coronavirus updates – live
- Coronavirus latest: at a glance
5.20pm BST
When cats get the coronavirus they show cold-like symptoms including runny nose, fever and cough, Russia’s federal veterinary service has reported.
In a statement carried by the Tass news agency, the service said:
According to the information published on the website of the World Organization for Animal Health [OIE], cats (both domestic and wild cats) and minks often exhibit clinical symptoms of an acute respiratory infection. Namely, the animals exhibit such symptoms as high fever, cough, sneezing, discharge from nose and eyes.
5.11pm BST
The World Health Organization has received reports of 100,000 new cases of coronavirus every day for the past five days, as the outbreak gathers pace in various regions around the world, its director general has said.
Tedros Adhanom Ghebreyesus also said that the WHO had resumed trials of hydroxychloroquine, an arthritis drug that had been used to treat Covid-19 patients, after reviewing data in studies that had apparently shown it was dangerous.
More than 100,000 cases of Covid-19 have been reported to WHO for each of the past five days.
The Americas continues to account for the most cases. For several weeks, the number of cases reported each day in the Americas has been more than the rest of the world put together. We are especially worried about Central and South America, where many countries are witnessing accelerating epidemics.
As you know, last week the Executive Group of the Solidarity Trial decided to implement a temporary pause of the hydroxychloroquine arm of the trial, because of concerns raised about the safety of the drug. This decision was taken as a precaution while the safety data were reviewed.
The Data Safety and Monitoring Committee of the Solidarity Trial has been reviewing the data. On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol. The Executive Group received this recommendation and endorsed continuation of all arms of the Solidarity Trial, including hydroxychloroquine
